Low delta sleep predicted a good clinical response to olanzapine administration in schizophrenic patients

Revista de Investigacion Clinica

Volumn 56, Issue 3, 2004, Pages 345-350

  Salín Pascual, Rafael J ^a,b   Herrera Estrella, Miguel ^c   Galicia Polo, Lourdes ^b   Rosas, Martha ^c   Brunner, Elizabeth ^d  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c Hospital Psiquiátrico FBA   (Mexico)

^d Eli and Lilly Mexico ^*  (Mexico)

Author keywords

Delta sleep; Olanzapine; Schizophrenia; Sleep

Indexed keywords

OLANZAPINE;

ACCLIMATIZATION; ADULT; AROUSAL; ARTICLE; BODY WEIGHT DISORDER; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; MEDICAL ASSESSMENT; MENTAL DISEASE; PREDICTION; PSYCHIATRIC DIAGNOSIS; SCHIZOPHRENIA; SCORING SYSTEM; SIDE EFFECT; SLEEP; SLEEP STAGE; SOMNOLENCE; TREATMENT OUTCOME; WEIGHT GAIN;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; FEMALE; HUMANS; MALE; SCHIZOPHRENIA; SLEEP STAGES;

EID: 4544345609     PISSN: 00348376     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Benson KL, Sullivan EV, Lim KO, et al. Slow wave sleep and computed tomographic measures of brain morphology in schizophrenia. Psychiatry Res 1996; 60: 125-34.
2. Benson KL, Zarcone VP. Slow wave sleep deficit: their magnitude, distribution and reliability [Abstract]. Sleep Res 1989; 18: 165.
3. Keshavan MS, Reynolds CF, Kupfer DJ. Electroencephalographic sleep in schizophrenia: a critical review. Compr Psychiatry 1990; 31: 34-7.
4. Tandon R. Cholinergic aspects of schizophrenia. Br J Psychiatry 1999; 37(Suppl.): 7-11.
5. Bymaster FB, Calligaro DO, Falcone JF, et al. Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology 1996; 14: 87-96.
6. Corbett R, Camacho F, Woods AT, et al. Antipsychotic agents antagonize non-competitive N-methyl-D-aspartate antagonist-induced behaviors. Psychopharmacology 1995; 120: 67-74.
7. Kay SR. Opler LA, Lindernmayer JP. Reliability and validity of the Positive and Negative Syndrome Scale for schizophrenic patients. Psychiatry Res 1987; 23: 99-110.
8. Addington D, Addington J, Schissel B. A depression rating scale for schizophrenics. Schizophr Res 1990; 3: 247-51.
9. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Washington, DC: National Institute of Health Publications; 1968.
10. Lauer CJ, Krieg JC. Slow-wave sleep and ventricular size: a comparative study in schizophrenia and major depression. Biol Psychiatry 1998; 44: 121-8.
11. Salin-Pascual RJ, Herrera-Estrella M, Galicia-Polo L, et al. Olanzapine acute administration in schizophrenic patients increases delta sleep and sleep efficiency. Biol Psychiatry 1999; 46: 141-3.
12. Borbely AA, Trachsel L, Tobler I. Effects of ritanserin on sleep stages and sleep EEG in the rat. Eur J Pharmacol 1988; 156: 275-8.
13. Sharpley AL, Vassallo CM, Cowen PJ. Olanzapine increases slow-wave sleep: Evidence for blockade of central 5-HT2C receptors in vivo. Biol Psychiatry 2000; 47: 468-70.